메뉴 건너뛰기




Volumn 15, Issue 10, 2016, Pages 1028-1034

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84979524800     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)30139-9     Document Type: Article
Times cited : (41)

References (23)
  • 1
    • 84919432580 scopus 로고    scopus 로고
    • Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
    • 1 Emberson, J, Lees, KR, Lyden, P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384 (2014), 1929–1935.
    • (2014) Lancet , vol.384 , pp. 1929-1935
    • Emberson, J.1    Lees, K.R.2    Lyden, P.3
  • 2
    • 84862629039 scopus 로고    scopus 로고
    • Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
    • 2 Wardlaw, JM, Murray, V, Berge, E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379 (2012), 2364–2372.
    • (2012) Lancet , vol.379 , pp. 2364-2372
    • Wardlaw, J.M.1    Murray, V.2    Berge, E.3
  • 3
    • 84883769537 scopus 로고    scopus 로고
    • Do risks outweigh benefits in thrombolysis for stroke?
    • 3 Brown, SG, Macdonald, SP, Hankey, GJ, Do risks outweigh benefits in thrombolysis for stroke?. BMJ, 347, 2013, f5215.
    • (2013) BMJ , vol.347 , pp. f5215
    • Brown, S.G.1    Macdonald, S.P.2    Hankey, G.J.3
  • 4
    • 84906706030 scopus 로고    scopus 로고
    • Questions about authorisation of alteplase for ischaemic stroke
    • 4 Shinton, R, Questions about authorisation of alteplase for ischaemic stroke. Lancet 384 (2014), 659–660.
    • (2014) Lancet , vol.384 , pp. 659-660
    • Shinton, R.1
  • 6
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • 6 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995), 1581–1587.
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 7
    • 84862625338 scopus 로고    scopus 로고
    • The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial
    • 7 Sandercock, P, Wardlaw, JM, Lindley, RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 379 (2012), 2352–2363.
    • (2012) Lancet , vol.379 , pp. 2352-2363
    • Sandercock, P.1    Wardlaw, J.M.2    Lindley, R.I.3
  • 8
    • 0033542395 scopus 로고    scopus 로고
    • Effects of tissue plasminogen activator for acute ischemic stroke at one year
    • 8 Kwiatkowski, TG, Libman, RB, Frankel, M, et al., for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 340 (1999), 1781–1787.
    • (1999) N Engl J Med , vol.340 , pp. 1781-1787
    • Kwiatkowski, T.G.1    Libman, R.B.2    Frankel, M.3
  • 9
    • 84880326684 scopus 로고    scopus 로고
    • Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the Third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
    • 9 IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the Third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol 12 (2013), 768–776.
    • (2013) Lancet Neurol , vol.12 , pp. 768-776
  • 10
    • 84924034778 scopus 로고    scopus 로고
    • Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (Third International Stroke Trial)
    • 10 Whiteley, WN, Thompson, D, Murray, G, et al. Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (Third International Stroke Trial). Stroke 45 (2014), 3612–3617.
    • (2014) Stroke , vol.45 , pp. 3612-3617
    • Whiteley, W.N.1    Thompson, D.2    Murray, G.3
  • 11
    • 39749111776 scopus 로고    scopus 로고
    • Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
    • 11 Slot, KB, Berge, E, Dorman, P, Lewis, S, Dennis, M, Sandercock, P, Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 336 (2008), 376–379.
    • (2008) BMJ , vol.336 , pp. 376-379
    • Slot, K.B.1    Berge, E.2    Dorman, P.3    Lewis, S.4    Dennis, M.5    Sandercock, P.6
  • 12
    • 84908572096 scopus 로고    scopus 로고
    • Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort
    • 12 Magalhaes, R, Abreu, P, Correia, M, Whiteley, W, Silva, MC, Sandercock, P, Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort. Cerebrovasc Dis 38 (2014), 46–54.
    • (2014) Cerebrovasc Dis , vol.38 , pp. 46-54
    • Magalhaes, R.1    Abreu, P.2    Correia, M.3    Whiteley, W.4    Silva, M.C.5    Sandercock, P.6
  • 13
    • 47349115423 scopus 로고    scopus 로고
    • Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke
    • 13 Sandercock, P, Lindley, R, Wardlaw, J, et al. Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials, 9, 2008, 37.
    • (2008) Trials , vol.9 , pp. 37
    • Sandercock, P.1    Lindley, R.2    Wardlaw, J.3
  • 14
    • 82255173763 scopus 로고    scopus 로고
    • Update on the Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
    • 14 Sandercock, P, Lindley, R, Wardlaw, J, et al. Update on the Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials, 12, 2011, 252.
    • (2011) Trials , vol.12 , pp. 252
    • Sandercock, P.1    Lindley, R.2    Wardlaw, J.3
  • 15
    • 84858274819 scopus 로고    scopus 로고
    • Statistical analysis plan for the Third International Stroke Trial (IST-3); part of a ‘thread’ of reports of the trial
    • 15 Sandercock, P, Lindley, R, Wardlaw, J, Whiteley, W, Murray, G, Statistical analysis plan for the Third International Stroke Trial (IST-3); part of a ‘thread’ of reports of the trial. Int J Stroke 7 (2012), 186–187.
    • (2012) Int J Stroke , vol.7 , pp. 186-187
    • Sandercock, P.1    Lindley, R.2    Wardlaw, J.3    Whiteley, W.4    Murray, G.5
  • 16
    • 0027937944 scopus 로고
    • A simple practical classification of cerebral infarcts on CT and its interobserver reliability
    • 16 Wardlaw, JM, Sellar, RJ, A simple practical classification of cerebral infarcts on CT and its interobserver reliability. AJNR Am J Neuroradiol 15 (1994), 1933–1939.
    • (1994) AJNR Am J Neuroradiol , vol.15 , pp. 1933-1939
    • Wardlaw, J.M.1    Sellar, R.J.2
  • 17
    • 0037167309 scopus 로고    scopus 로고
    • Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial
    • 17 Koops, L, Lindley, RI, Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ, 325, 2002, 415.
    • (2002) BMJ , vol.325 , pp. 415
    • Koops, L.1    Lindley, R.I.2
  • 18
    • 84929294516 scopus 로고    scopus 로고
    • Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial
    • 18 Lindley, RI, Wardlaw, JM, Whiteley, WN, et al. Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial. Stroke 46 (2015), 746–756.
    • (2015) Stroke , vol.46 , pp. 746-756
    • Lindley, R.I.1    Wardlaw, J.M.2    Whiteley, W.N.3
  • 19
    • 84966357366 scopus 로고    scopus 로고
    • The Third International Stroke Trial (IST-3) 2000–2015 [dataset]. University of Edinburgh and Edinburgh Clinical Trials Unit
    • (accessed July 7, 2016).
    • 19 Sandercock, P, Wardlaw, J, Lindley, R, Cohen, G, Whiteley, W, The Third International Stroke Trial (IST-3) 2000–2015 [dataset]. University of Edinburgh and Edinburgh Clinical Trials Unit. http://datashare.is.ed.ac.uk/handle/10283/1931, 2016 (accessed July 7, 2016).
    • (2016)
    • Sandercock, P.1    Wardlaw, J.2    Lindley, R.3    Cohen, G.4    Whiteley, W.5
  • 20
    • 84892614609 scopus 로고    scopus 로고
    • Increasing value and reducing waste: addressing inaccessible research
    • 20 Chan, AW, Song, F, Vickers, A, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 383 (2014), 257–266.
    • (2014) Lancet , vol.383 , pp. 257-266
    • Chan, A.W.1    Song, F.2    Vickers, A.3
  • 21
    • 0022640774 scopus 로고
    • Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
    • 21 Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986), 397–402.
    • (1986) Lancet , vol.1 , pp. 397-402
  • 22
    • 0023805341 scopus 로고
    • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
    • 22 ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988), 349–360.
    • (1988) Lancet , vol.2 , pp. 349-360
  • 23
    • 84953395191 scopus 로고    scopus 로고
    • Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN
    • 23 Wahlgren, N, Moreira, T, Michel, P, et al. for ESO-KSU ESO ESMINT, ESNR and EAN. Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11 (2016), 134–147.
    • (2016) Int J Stroke , vol.11 , pp. 134-147
    • Wahlgren, N.1    Moreira, T.2    Michel, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.